Freiburg chemist Dr Tobias Schnitzer receives €1.5 million from the Vector Foundation to develop sustainable amidation reactions.

These reactions do not require toxic reagents and are highly energy-efficient. Schnitzer also relies on Artificial Intelligence in his research.

Amidations play a major role in the chemical industry. The new process could make an important contribution to more environmentally friendly production.

During cell division, chromosomal abnormalities – defects in chromosome number or structure – can occur, which can cause particularly aggressive forms of cancer. A new study has shed light on how chromosomal abnormalities arise in normal cells, the rates at which they do so, and how these rates are affected by various factors. To do this, the scientists developed a novel and versatile artificial intelligence (AI) tool called MAGIC, which combines automated microscopy and image analysis with single-cell genome sequencing. Understanding the molecular origins of cancer in this way could pave the way for better genetic detection tools and potential medical prevention strategies in the future.

Ribosomes are complex molecular machines that translate genetic code into proteins essential for all life. Researchers have used AI and other cutting-edge techniques to create the first near-continuous "molecular movie" of ribosome formation, capturing sixteen stages that show how this fundamental cellular machine comes together in real time. The work establishes a new paradigm for studying dynamic molecular machines, setting the stage for AI-driven structural biology that will capture life's core processes in motion. 

The Boston Business Journal’s BostInno Fire Awards 2025, honoring the region’s most innovative and impactful companies, has officially announced its annual honorees. Insilico Medicine, a global clinical-stage biotechnology company powered by generative artificial intelligence (AI), was recognized among Boston’s leading innovators for its pioneering work throughout Biotech.